Gastroesophageal reflux disease (GERD) is associated with a significant increase in the risk for lung cancer, according to study results presented at Digestive Disease Week (DDW), held May 3 to 6, ...

A new study of 18,932 metastatic colorectal cancer patients reveals that microsatellite instability, albumin levels, and ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

CNN anchor and breast cancer patient Sara Sidner, Dr. Vinod Balachandran, and Novartis U.S. president Victor Bulto discussed ...

Received a "Study May Proceed” letter from the FDA for the Phase 2 trial for the treatment of FAP. This trial, run by CP-CTNet and financially supported by the NCI's Division of Cancer Prevention, ...